The Supreme Court of California is gearing up to decide an important question for the future of product liability law: Do drug manufacturers have ...

Gilead Sciences posted robust revenue and EPS growth, exceeding expectations, and management raised full-year guidance.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of ...

Nov 6 (Reuters) - Gilead Sciences (GILD.O), opens new tab reported ... Pharmaceuticalscategory US FDA approves Johnson & Johnson's device for heart condition 6:32 PM UTC Lucid beat Wall Street ...

Gilead Sciences Inc.’s stock rose 2.7% in after-hours trading Wednesday, after the biotech blew past third-quarter earnings estimates and raised its guidance, boosted by demand for its HIV and ...

Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

Johnson & Johnson is a global leader in the pharmaceutical, medical device and consumer ... which closed at $54.92 on Oct. 14. Gilead Sciences is a biopharmaceutical company that develops ...

These are the highest-quality dividend growth stocks in Dividend Radar, a weekly automatically generated spreadsheet of ...

Leading pharmaceutical and health-care companies have gained confidence from the positive results from previous editions of ...

About Gilead Sciences, Inc. Gilead Sciences ... Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...